It demonstrated beneficial effects in mitigating MI/R injury by suppressing the HMGB1/TLR4/NF-κB/NLRP3 inflammasome signaling pathway, leading to a significant reduction in MI size and enhancement of cardiac function (187). Here, NFKB1 is linked to myocardial infarction.